BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25447569)

  • 1. Thalidomide for treatment of gastrointestinal angiodysplasia in patients with left ventricular assist devices: case series and treatment protocol.
    Draper K; Kale P; Martin B; Kelly Cordero R; Ha R; Banerjee D
    J Heart Lung Transplant; 2015 Jan; 34(1):132-134. PubMed ID: 25447569
    [No Abstract]   [Full Text] [Related]  

  • 2. Octreotide for recurrent intestinal bleeding due to ventricular assist device.
    Coutance G; Saplacan V; Belin A; Repessé Y; Buklas D; Massetti M
    Asian Cardiovasc Thorac Ann; 2014 Mar; 22(3):350-2. PubMed ID: 24585917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalidomide for the treatment of angiodysplasia in a patient with acute upper gastrointestinal haemorrhage.
    Bond A; Ahmed W
    BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26791122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thalidomide in angiodysplasia-related bleeding.
    Boey JP; Hahn U; Sagheer S; McRae SJ
    Intern Med J; 2015 Sep; 45(9):972-6. PubMed ID: 26332623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Use of Thalidomide in Recurrent Gastrointestinal Tract Bleeding in Patients with Left Ventricular Assist Devices: A Case Series.
    Chan LL; Lim CP; Lim CH; Tan TE; Sim D; Sivathasan C
    Heart Lung Circ; 2017 Oct; 26(10):1101-1104. PubMed ID: 28131776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thalidomide therapy for gastrointestinal angiodysplasia].
    Bélard E; Foss CH; Christensen LA; Schmidt P; Nøjgaard C
    Ugeskr Laeger; 2009 Nov; 171(47):3454-5. PubMed ID: 19925735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thalidomide for the treatment of chronic gastrointestinal bleeding from angiodysplasias: a case series.
    Kamalaporn P; Saravanan R; Cirocco M; May G; Kortan P; Kandel G; Marcon N
    Eur J Gastroenterol Hepatol; 2009 Dec; 21(12):1347-50. PubMed ID: 19730385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalidomide for the treatment of bleeding angiodysplasias.
    Shurafa M; Kamboj G
    Am J Gastroenterol; 2003 Jan; 98(1):221-2. PubMed ID: 12526972
    [No Abstract]   [Full Text] [Related]  

  • 9. Thalidomide for treatment of bleeding angiodysplasias during hemodialysis.
    Mimidis K; Kaliontzidou M; Tzimas T; Papadopoulos V
    Ren Fail; 2008; 30(10):1040-1. PubMed ID: 19016158
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticoagulation with apixaban in a patient with a left ventricular assist device and gastrointestinal bleeding: A viable alternative to warfarin?
    Pollari F; Fischlein T; Fittkau M; Santarpino G
    J Thorac Cardiovasc Surg; 2016 Apr; 151(4):e79-81. PubMed ID: 26586358
    [No Abstract]   [Full Text] [Related]  

  • 11. Beneficial effects and reversion of vascular lesions by thalidomide in a patient with bleeding portal hypertensive enteropathy.
    Jimenez-Saenz M; Romero-Vazquez J; Caunedo-Alvarez A; Maldonado-Perez B; Gutierrez JM
    Dig Liver Dis; 2010 Mar; 42(3):232-3. PubMed ID: 19574114
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful treatment of thalidomide for recurrent bleeding due to gastric angiodysplasia in hereditary hemorrhagic telangiectasia.
    Wang XY; Chen Y; Du Q
    Eur Rev Med Pharmacol Sci; 2013 Apr; 17(8):1114-6. PubMed ID: 23661527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of new anticoagulant drugs in ventricular assist devices: Another brick in the wall?
    Miceli A; Glauber M
    J Thorac Cardiovasc Surg; 2016 Apr; 151(4):e83-4. PubMed ID: 26846871
    [No Abstract]   [Full Text] [Related]  

  • 14. Digoxin Is Associated With a Decreased Incidence of Angiodysplasia-Related Gastrointestinal Bleeding in Patients With Continuous-Flow Left Ventricular Assist Devices.
    Vukelic S; Vlismas PP; Patel SR; Xue X; Shitole SG; Saeed O; Sims DB; Chinnadurai T; Shin JJ; Forest SJ; Goldstein DJ; Jorde UP
    Circ Heart Fail; 2018 Aug; 11(8):e004899. PubMed ID: 30354557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pulmonary hypertension in a patient with talidomide].
    Hurtado García R; García Rodríguez M
    Farm Hosp; 2013; 37(3):267-9. PubMed ID: 23789805
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and In Vitro Evidence That Left Ventricular Assist Device-Induced von Willebrand Factor Degradation Alters Angiogenesis.
    Bartoli CR; Zhang DM; Hennessy-Strahs S; Kang J; Restle DJ; Bermudez C; Atluri P; Acker MA
    Circ Heart Fail; 2018 Sep; 11(9):e004638. PubMed ID: 30354363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin analogues for bleeding gastrointestinal angiodysplasias: when should thalidomide be prescribed?
    Molina-Infante J; Perez-Gallardo B
    Dig Dis Sci; 2011 Jan; 56(1):266-7. PubMed ID: 21046246
    [No Abstract]   [Full Text] [Related]  

  • 18. Unsuccessful octreotide treatment of the watermelon stomach.
    Barbara G; De Giorgio R; Salvioli B; Stanghellini V; Corinaldesi R
    J Clin Gastroenterol; 1998 Jun; 26(4):345-6. PubMed ID: 9649027
    [No Abstract]   [Full Text] [Related]  

  • 19. Danazol treatment of gastrointestinal bleeding in left ventricular assist device-supported patients.
    Schettle S; Bawardy BA; Asleh R; Sherazi S; Rajan E; Stulak J; Pereira N
    J Heart Lung Transplant; 2018 Aug; 37(8):1035-1037. PubMed ID: 29907501
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of multiple small bowel angiodysplasias causing severe life-threatening bleeding with thalidomide.
    Kirkham SE; Lindley KJ; Elawad MA; Blanshard C; Shah N
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):585-7. PubMed ID: 16707986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.